Genesis Drug Discovery & Development

Executive Summary

Genesis Drug Discovery & Development (GD3) is a fully integrated contract research organization (CRO) based in San Diego, California, providing comprehensive drug discovery and development services. Founded in 2009, GD3 supports clients from target discovery through IND filing and management of Phase I–III clinical trials. As a private, pre-clinical stage CRO, the company leverages its expertise to accelerate drug development programs for pharmaceutical and biotech partners. Its service offerings encompass the entire drug development continuum, positioning GD3 as a versatile partner for both early-stage research and late-stage clinical management. The company's long-standing presence in the industry and broad service portfolio suggest a stable revenue stream from client engagements, though as a service provider, its growth is largely dependent on the success of client programs and the overall R&D spending environment.

Upcoming Catalysts (preview)

• TBDPotential expansion of service capabilities or new partnerships60% success